New Zealand - Export of Vaccines for Human Use
Since 2014, New Zealand Export of Vaccines for Human Use grew 50.9% year on year. At $5,259,648.84 in 2019, the country was ranked number 36 among other countries in Export of Vaccines for Human Use. New Zealand is overtaken by Slovakia, which was number 35 with $6,458,074.63 and is followed by Lithuania with $4,640,462.45. Belgium ranked the highest with $6,511,782,808.63 in 2019, a growth of 2.7% versus 2018. Ireland, United Kingdom and France respectively ranked number 2, 3 and 4 in this ranking. Nicaragua witnessed the best average annual growth at +356.4% per year, while Dominican Republic witnessed the worst performance at -87.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 5,259,648.83 |
| 2018 | 4,620,273.00 |
| 2017 | 6,886,800.00 |
| 2016 | 244,365.02 |
| 2015 | 1,236,348.50 |
Download all data from 1989 to 2019
How does New Zealand rank in Export of Vaccines for Human Use?
| # | 115 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
6,511,782,808.63 | 2019 | +2.7 % | -9.2 % | View data | |
| 2 |
#2
Ireland
|
5,792,918,864.55 | 2019 | -0.9 % | +16.3 % | View data | |
| 35 |
#35
Slovakia
|
6,458,074.63 | 2019 | -15.8 % | +9.8 % | View data | |
| 36 |
#36
New Zealand
|
5,259,648.83 | 2019 | +13.8 % | +50.9 % | View data | |
| 37 |
#37
Lithuania
|
4,640,462.45 | 2019 | -7.4 % | -13.9 % | View data | |